中 国 肺 癌 杂 志 2 0 1 0 年 2 月 第 1 3 卷 第 2 期 C h i n J L u n g C a n c e r, Fe b r u a r y 2 0 1 0 , Vo l . 1 3 , No. 2 ·132· BSD2000深部热疗联合PT方案化疗 在非小细胞肺癌中的应用 杨孟祥 赵军 王彦文 【摘要】 背景与目的 通过与PT方案单独化疗的对比观察，探讨BSD2000深部热疗联合PT方案化疗治疗非小 细胞肺癌 (non-small cell lung cancer, NSCLC)的方法，观察其近期疗效、毒副作用及生存质量改善率方面是否存在 优势。方法 选择NSCLC患者60例，随机分为治疗组和对照组，各30例。治疗组：紫杉醇(paclitaxel, PTX)135 mg/ m 2 ivdirp 3 h qd d1+顺铂( cisplatin, DDP)20 mg/m 2 ivdirp qd d1-5，同时于d1、d4化疗结束后2 h内进行BSD2000热疗机 精确定位热疗1 h，21天为1周期，共3周期。对照组： PTX 135 mg/m 2 ivdirp 3 h qd d1+DDP 20 mg/m 2 ivdirp qd d1-5， 21天为1周期，共3周期，不进行热疗。对比两组的有效率、毒副作用及生存质量改善率。结果 治疗组有效率、生 存质量改善率分别为63.33%、 76.67%，对照组分别为36.67%、40.00%，两组有效率及生存质量改善率有统计学差异 (P<0.05)。主要毒副作用均为骨髓抑制和消化道反应，两组无统计学差异(P>0.05)。结论 BSD2000深部热疗联 合PT方案化疗治疗d可明显提高疗效，有效率及生存质量改善率优于单纯PT方案化疗，毒副作用可耐受。 【关键词】 热疗；化疗；肺肿瘤；紫杉醇；顺铂 【中图分类号】 R734.2 【Abstract】 Background and objective The aim of this study is to determine the short-term efficacy, toxicity and the rate of life-quality improvement of BSD2000 deep hyperthermia combined with chemotherapy of PT regimen in patients with non-small cell lung cancer (NSCLC) by comparation with PT regimen alone. Methods Sixty patients with NSCLC were randomly divided into the treatment group and control group, with 30 each. The treatment group was treated with chemotherapy (paclitaxel:135mg/m 2 ivdirp 3 h qd d1+cisplatin: 20 mg/m 2 ivdirp qd d1-5) in combination with BSD2000 deep hyperthermia, and hyperthermia was positioned precisely and maintained for 60 min (2 times a cycle: d1, 4 after the end of chemotherapy within two hours). The control group was treated with chemotherapy alone. Treatment response in both groups were evaluated as well as side-effects after 3 cycles. By observing the results, comparing response rate, toxic side effects and quality of life improvement rate in two groups. Results The efficiency and the rate of life-quality improvement in the treatment group were 63.33%, 76.67% respectively, and 36.67%, 40.00% in the control group respectively. There were significant differences between two groups (P<0.05). The main side-effects were myelosuppression and gastrointestinal reactions, no significant difference between two groups (P>0.05). Conclusion BSD2000 deep hyperthermia combined with chemotherapy in patients with NSCLC can significantly increase the efficacy, response rate and quality of life improvement and without increasing sideeffects compared to chemotherapy alone. 【Key words】 Hyperthermia; Chemotherapy; Lung neoplasms; Paclitaxel; Cisplatin 恶性肿瘤已成为常见病、多发病，其死亡率已跃 居所有疾病死因的第二位，其中肺癌在恶性肿瘤中的发 病率及死亡率均占居首位，而非小细胞肺癌(non-small cell lung cancer, NSCLC)又约占肺癌的80%，化疗是治疗 NSCLC的主要手段之一，但NSCLC对化疗不甚敏感，并 且效果差、生存期短。为提高肿瘤的治疗效果，我院引 进了目前先进的美国BSD2000相控阵聚焦深部肿瘤热疗 系统，采用热疗联合化疗的方法治疗NSCLC 30例，以期 取得较好疗效。 作者单位：252000 聊城，山东省聊城市人民医院肿瘤内科(通讯作
·133· 中 国 肺 癌 杂 志 2 0 1 0 年 2 月 第 1 3 卷 第 2 期 C h i n J L u n g C a n c e r, Fe b r u a r y 2 0 1 0 , Vo l . www.lungca.org 中 国 肺 癌 杂 志 2 0 1 0 年 2 月 第 1 3 卷 第 2 期 C h i n J L u n g C a n c e r, Fe b r u a r y 2 0 1 0 , Vo l . 1 3 , No. 2 ·134· www.lungca.org ·135· 中 国 肺 癌 杂 志 2 0 1 0 年 2 月 第 1 3 卷 第 2 期 C h i n J L u n g C a n c e r, Fe b r u a r y 2 0 1 0 , Vo l . This book provides a comprehensive coverage and a succinct overview of the current status of supportive cancer care with Chinese medicine written by leading experts in the field. The chapters coherently present an overview on the major treatment approaches of Chinese medicine and progresses made with different important aspects on supportive cancer care with acupuncture, herbal therapy and qigong. Moreover, there are reviews on the evidences and efficacies of Chinese medicine for controlling radiation-induced injuries, chemotherapy-related side effects, as well as pain control with Chinese medicine. In order to provide information from basic science at the bench to the patient's bedside, modern researches and clinical trials would be overviewed so as to give an up-to-date and realistic evaluation of a therapy's utility for cancer patients. It is also worth noting that toxicology, safety and herb-drug interactions are the main concerns of using Chinese medicine combined with Western medicine. A chapter will expound on these issues and there will also be chapters discussing integrative Chinese nese and Western medicine, as well as cancer prevention with Chinese medicine. This book presents state-of-the-art knowledge on supportive cancer care... more on http: // springer.com/978-90-481-3554-7 Presents state-of-the-art knowledge on supportive cancer care with Chinese medicine C ontains unparallel topics of interest in supportive cancer care with Chinese medicine Expounds an important topic as more and more cancer patients survive after primary treatment Features international opinion leaders' views Provides theoretical and evidence-based information on the supportive cancer care with Chinese medicine and its utility in improving cancer management as an ultimate goal. 
Supportive Cancer Care with Chinese Medicine
This book provides a comprehensive coverage and a succinct overview of the current status of supportive cancer care with Chinese medicine written by leading experts in the field. The chapters coherently present an overview on the major treatment approaches of Chinese medicine and progresses made with different important aspects on supportive cancer care with acupuncture, herbal therapy and qigong. Moreover, there are reviews on the evidences and efficacies of Chinese medicine for controlling radiation-induced injuries, chemotherapyrelated side effects, as well as pain control with Chinese medicine. In order to provide information from basic science at the bench to the patient's bedside, modern researches and clinical trials would be overviewed so as to give an up-to-date and realistic evaluation of a therapy's utility for cancer patients. It is also worth noting that toxicology, safety and herb-drug interactions are the main concerns of using Chinese medicine combined with Western medicine. A chapter will expound on these issues and there will also be chapters discussing integrative Chinese nese and Western medicine, as well as cancer prevention with Chinese medicine. This book presents state-of-the-art knowledge on supportive cancer care... more on http://springer.com/978-90-481-3554-7 ▶Presents state-of-the-art knowledge on supportive cancer care with Chinese medicine ▶Contains unparallel topics of interest in supportive cancer care with Chinese medicine ▶Expounds an important topic as more and more cancer patients survive after primary treatment ▶Features international opinion leaders' views ▶Provides theoretical and evidence-based information on the supportive cancer care with Chinese medicine and its utility in improving cancer management as an ultimate goal.
